Medications That Can Worsen Arthritis
Many people are surprised to learn that some of the most commonly prescribed drugs may, in certain circumstances, contribute to joint or bone problems. This page reviews the medications that worsen arthritis in the integrative and functional-medicine literature — the so-called NSAID paradox, fluoroquinolone antibiotics, long-term corticosteroids, and drug-induced nutrient depletions. Each claim is graded for the strength of its evidence, because some associations are well established while others remain emerging or contested.
Key takeaways
- Some functional-medicine and prolotherapy sources argue long-term NSAID use may slow cartilage repair — a Contested view that mainstream rheumatology does not accept; NSAIDs are still recommended for short-term symptom control.
- Fluoroquinolone antibiotics carry an FDA boxed warning for tendinopathy and tendon rupture Strong; their direct cartilage toxicity is Emerging.
- Long-term corticosteroids are well documented to cause bone loss and, rarely, osteonecrosis Strong.
- Several drugs deplete joint-supporting nutrients: diuretics can raise uric acid and trigger gout, and PPIs can lower magnesium Strong.
- Decisions about any of these medications belong to your prescribing physician.
Conventional medicine uses pharmaceuticals to manage the symptoms of arthritis and the metabolic conditions that often accompany it. A critical but underreported theme in holistic literature is the iatrogenic (medically induced) contribution to joint damage: the idea that, in some cases, the very drugs used to relieve symptoms may add to the underlying burden on cartilage, bone, and connective tissue.1 We present these claims honestly and with their evidence grade attached — not as settled fact, and never as a reason to abandon a prescription.
The NSAID Paradox Contested
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and diclofenac are the primary pharmacological tool for osteoarthritis pain worldwide, and major rheumatology guidelines still recommend them for short-term relief. So does do NSAIDs make arthritis worse have any basis? A strand of functional-medicine and prolotherapy literature argues there is a paradox: while NSAIDs reduce acute pain effectively, some sources contend their long-term use may interfere with the joint's own repair process.2
Proposed mechanism (NSAID paradox cartilage hypothesis):
In a healthy joint, chondrocytes continuously rebuild the cartilage matrix. Prostaglandins — particularly PGE2 — are described as messenger molecules that help stimulate this chondrocyte activity and matrix synthesis. Because NSAIDs work by inhibiting cyclooxygenase (COX-1 and COX-2) and thereby suppressing prostaglandin production, proponents argue that long-term use may also blunt the signal that drives cartilage repair.2 These sources cite laboratory and animal studies reporting inhibited chondrocyte proliferation and reduced synthesis of glycosaminoglycans (GAGs), collagen, and proteoglycans, and they point to observational data suggesting faster radiographic osteoarthritis progression in some NSAID users.2
How to read this honestly. Mainstream rheumatology does not accept "NSAIDs accelerate arthritis" as established. The "accelerates OA" claim above is drawn largely from functional-medicine and prolotherapy literature, and much of the mechanistic evidence is from in vitro and animal models rather than controlled human trials; observational associations can reflect that people with worse, faster- progressing arthritis simply take more NSAIDs (confounding by indication). That is why we grade this section Contested. NSAIDs remain a standard, guideline-supported option for short-term pain. If you are weighing long-term use, that is exactly the kind of conversation to have with your physician — who may discuss the lowest effective dose, periodic review, and physician-supervised dietary and lifestyle alternatives. Oxidative stress and nutrient status, discussed under our root causes of arthritis, form part of that bigger picture.
Fluoroquinolone Antibiotics Strong (tendon) Emerging (cartilage)
Fluoroquinolones — including ciprofloxacin, levofloxacin, and ofloxacin — are broad-spectrum antibiotics. Their link to fluoroquinolone tendon damage is one of the better-documented drug-musculoskeletal associations: the U.S. FDA carries a boxed warning for tendinitis and spontaneous tendon rupture, most notoriously of the Achilles tendon.34 That tendon and FDA-warning risk is well established, so we badge it Strong. The claim that these drugs are directly toxic to articular cartilage in humans is more preliminary and is graded Emerging.
Proposed mechanism:
- MMP upregulation. Fluoroquinolones are reported to upregulate matrix metalloproteinases — particularly MMP-1 and MMP-3 — in tendon and cartilage cells. These enzymes degrade Type I collagen and weaken the extracellular matrix.56
- Oxidative stress. They are described as inducing reactive oxygen species (ROS) and nitric oxide, which can trigger tenocyte apoptosis and necrosis.4
- Magnesium chelation. Fluoroquinolones bind metallic ions, especially magnesium. Local magnesium chelation is proposed to impair integrin and MAPK signaling, weakening cell-to-matrix adhesion and the tissue's reparative capacity.4
The practical point is not "never take antibiotics" — fluoroquinolones can be the right, even life-saving, choice in serious infections. It is that the risk is real enough that regulators warn about it, and that you and your prescriber should weigh it, especially if you have a history of tendon problems or take corticosteroids concurrently.
Long-Term Corticosteroids Strong
Corticosteroids such as prednisone and dexamethasone are powerful and genuinely valuable for suppressing severe autoimmune flares in rheumatoid and psoriatic arthritis. The concern here is specifically long-term use, where the bone toll is well documented — hence the Strong grade. This is about long-term corticosteroids and bone loss, not short courses.
Proposed mechanism:
- Disrupted calcium balance. Corticosteroids decrease intestinal calcium absorption while increasing renal calcium excretion.7
- Osteoblast apoptosis. They induce apoptosis of osteoblasts (bone- forming cells) and osteocytes while prolonging the lifespan of bone-resorbing osteoclasts, producing glucocorticoid-induced osteoporosis that weakens subchondral bone.8
- Osteonecrosis (AVN). In some cases they compromise the microvascular blood supply to bone, precipitating osteonecrosis (avascular necrosis), which can lead to joint collapse.
Physicians actively manage these risks — for example with the lowest effective dose, limited duration, and bone-protective monitoring. None of that is something to attempt alone; it is a reason to keep your rheumatology follow-ups.
Drug-Induced Nutrient Depletions
Long-term management of metabolic and gastrointestinal conditions can quietly deplete nutrients that joints and bone depend on — the drug-induced nutrient depletion problem. Evidence varies by drug and nutrient, so the badges below differ.
Proton Pump Inhibitors (PPIs) Strong (magnesium)
PPIs such as omeprazole and pantoprazole raise gastric pH, which impairs absorption of several minerals. Long-term use is strongly correlated with hypomagnesemia and is also linked to vitamin B12 depletion and reduced calcium absorption.79 Low magnesium removes a buffer against systemic inflammation and may dysregulate calcium deposition in bone and joint tissue. The PPI–magnesium link is well documented, so we grade it Strong.
Statins Emerging (CoQ10 symptoms)
Statins lower cholesterol by inhibiting HMG-CoA reductase in the mevalonate pathway — the same pathway that produces Coenzyme Q10 (CoQ10), which mitochondria use to make ATP.10 Statin-associated myopathy (muscle pain and weakness) is a recognized effect that can compromise joint stability and mimic an arthritis flare. However, the specific claim that CoQ10 depletion causes these musculoskeletal symptoms — and that CoQ10 supplementation reliably relieves them — remains Emerging and is not consistently supported by trials.11
Thiazide & Loop Diuretics Strong (gout)
Thiazide and loop diuretics (such as hydrochlorothiazide and furosemide), used for hypertension and fluid overload, increase renal reabsorption of uric acid while depleting magnesium and potassium.10 The resulting rise in serum uric acid is a well-recognized iatrogenic trigger for acute gout attacks, so this is graded Strong.1 If you track your labs, see our guide to arthritis inflammation biomarkers, where uric acid and related markers and their optimal targets are explained.
Master Reference Table
The table below summarizes the drug classes discussed above, their proposed mechanisms, the reported effect on joints or bone, and our evidence grade. Read every badge in context — and remember this is a reference, not a recommendation to change anything.
| Drug class | Examples | Proposed mechanism | Effect on joints / bone | Evidence badge |
|---|---|---|---|---|
| NSAIDs | Ibuprofen, naproxen, diclofenac | COX-1/COX-2 inhibition lowers PGE2, said to suppress chondrocyte matrix synthesis (GAGs, collagen, proteoglycans) | Claimed reduced cartilage repair; faster radiographic OA progression in some users (functional-medicine / prolotherapy framing) | Contested |
| Fluoroquinolones | Ciprofloxacin, levofloxacin, ofloxacin | MMP-1/MMP-3 upregulation, ROS/oxidative stress, magnesium chelation impairing matrix adhesion | Tendinopathy & rupture (FDA boxed warning); proposed cartilage/chondrocyte toxicity | Strong (tendon) Emerging (cartilage) |
| Corticosteroids (long-term) | Prednisone, dexamethasone | Osteoblast/osteocyte apoptosis, prolonged osteoclast survival, reduced calcium absorption, impaired bone microvasculature | Glucocorticoid-induced osteoporosis; osteonecrosis / avascular necrosis (AVN) | Strong |
| Proton pump inhibitors | Omeprazole, pantoprazole | Elevated gastric pH impairs absorption of magnesium, B12, and calcium | Hypomagnesemia (loss of anti-inflammatory buffer); dysregulated bone/joint calcium | Strong (magnesium) |
| Statins | Atorvastatin, simvastatin | HMG-CoA reductase inhibition also lowers CoQ10 in the mevalonate pathway | Statin-associated myopathy / musculoskeletal pain that can mimic arthritis flares | Strong (myopathy) Emerging (CoQ10 link) |
| Thiazide & loop diuretics | Hydrochlorothiazide, furosemide | Increased renal uric acid reabsorption; magnesium and potassium depletion | Elevated uric acid → iatrogenic trigger for acute gout | Strong (gout) |
Related pages
Root Causes of Arthritis
How oxidative stress, nutrient status, and metabolic dysfunction set the stage for joint damage — context for the depletions above.
Biomarkers to Track
Uric acid, vitamin D, hs-CRP and other markers — what they mean and their optimal targets.
Anti-Inflammatory Plan
Physician-supervised dietary and lifestyle approaches to discuss as part of a bigger picture.
Frequently asked questions
Can NSAIDs make arthritis worse over time?
Some research suggests that while NSAIDs reduce short-term pain, long-term use may interfere with cartilage repair. This is a Contested topic in mainstream rheumatology, which still recommends NSAIDs for short-term symptom control. This page is educational only; never start or stop a medication without speaking to your prescribing physician.
Which medications are linked to joint or tendon problems?
Reported associations in the literature include fluoroquinolone antibiotics with tendon and cartilage toxicity, long-term corticosteroids with bone deterioration, and drug-induced nutrient depletions from PPIs, statins, and diuretics (the latter linked to uric acid elevation and gout). Discuss any concerns with your doctor.
Should I stop my arthritis medication?
No. This site does not give medical advice. Medication decisions belong to the prescribing physician, and you should never stop a prescribed medication without speaking to them first.
References
- Drug-Induced Nutrient Depletion Chart — ProHealth Seminars. prohealthseminars.com
- Cartilage Degeneration with NSAIDs — Caring Medical. caringmedical.com
- Fluoroquinolones and Tendinopathy: A Systematic Review of the Literature — PMC. pmc.ncbi.nlm.nih.gov
- Fluoroquinolone-Induced Achilles Tendon Damage: Collagen Type I Alterations — PMC. pmc.ncbi.nlm.nih.gov
- New insights in extracellular matrix remodeling and collagen turnover after ciprofloxacin — PMC. pmc.ncbi.nlm.nih.gov
- Contrasting effects of fluoroquinolones on MMP-1 and -13 in human tendon-derived cells — PubMed. pubmed.ncbi.nlm.nih.gov
- Drug-Induced Nutrient Depletions: What Pharmacists Need to Know — U.S. Pharmacist. uspharmacist.com
- Osteoarthritis associated with estrogen deficiency (bone metabolism context) — PMC. pmc.ncbi.nlm.nih.gov
- Drug-Induced Nutrient Depletion — Hayden Institute (functional medicine). haydeninstitute.com
- Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update — PMC. pmc.ncbi.nlm.nih.gov
- Do medicines commonly used by older adults impact their nutrient status? — PMC. pmc.ncbi.nlm.nih.gov